home / stock / tbgnf / tbgnf short
Short Information | Oxurion NV (OTCMKTS:TBGNF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 46,979 |
Total Actual Volume | 76,930 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 18 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 2,349 |
Average Short Percentage | 88.38% |
Is there a TBGNF Short Squeeze or Breakout about to happen?
See the TBGNF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
09-09-2021 | $2.61 | $2.61 | $2.61 | $2.61 | 500 | 400 | 80% |
12-29-2020 | $3 | $3 | $3 | $3 | 12,500 | 12,500 | 100% |
12-28-2020 | $3 | $3 | $3 | $3 | 3,500 | 3,500 | 100% |
12-08-2020 | $3.21 | $3.21 | $3.21 | $3.21 | 100 | 100 | 100% |
02-12-2020 | $3.61 | $3.49 | $3.61 | $3.49 | 28,150 | 100 | 0.36% |
02-11-2020 | $3.75 | $3.80 | $3.80 | $3.75 | 2,300 | 1,750 | 76.09% |
02-10-2020 | $3.69 | $3.75 | $3.75 | $3.69 | 26,100 | 26,000 | 99.62% |
08-20-2019 | $3.68 | $3.49 | $3.68 | $3.49 | 1,600 | 650 | 40.62% |
04-23-2019 | $4.40 | $4.40 | $4.40 | $4.40 | 1,000 | 800 | 80% |
04-16-2019 | $4.44 | $4.44 | $4.44 | $4.44 | 150 | 150 | 100% |
01-07-2019 | $3.87 | $3.87 | $3.87 | $3.87 | 100 | 100 | 100% |
12-21-2018 | $3.90 | $3.90 | $3.90 | $3.90 | 219 | 219 | 100% |
12-20-2018 | $4.03 | $4.03 | $4.03 | $4.03 | 100 | 100 | 100% |
11-30-2018 | $4.35 | $4.35 | $4.35 | $4.35 | 100 | 100 | 100% |
11-28-2018 | $4.40 | $4.40 | $4.40 | $4.40 | 100 | 100 | 100% |
11-26-2018 | $4.47 | $4.47 | $4.47 | $4.47 | 100 | 100 | 100% |
11-20-2018 | $4.51 | $4.51 | $4.51 | $4.51 | 100 | 100 | 100% |
11-19-2018 | $4.70 | $4.70 | $4.70 | $4.70 | 100 | 100 | 100% |
11-16-2018 | $4.78 | $4.78 | $4.78 | $4.78 | 100 | 100 | 100% |
07-12-2018 | $N/A | $9.075 | $N/A | $N/A | 11 | 10 | 90.91% |
News, Short Squeeze, Breakout and More Instantly...
Publication Annual Report – Annual Shareholders' Meeting Leuven, BELGIUM – April 15, 2024 – 05:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has today published its annual report for the financial year 2023. The...
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program Eleventh tranche fully issued and paid-up Leuven, BELGIUM, 10 April 2024 – 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, today communicates ...
Postponement Annual Shareholders Meeting - Amendment financial calendar Leuven, BELGIUM – April 5, 2024 – 02:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today made the following announcement regarding its financial c...